122 related articles for article (PubMed ID: 38602755)
1. [Mechanism study on the effect of androgen antagonism in prostate cancer].
Song X; Song Q; Wang R; Zuo QJ; Zhang ZY
Zhonghua Nan Ke Xue; 2023 May; 29(5):402-408. PubMed ID: 38602755
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
[TBL] [Abstract][Full Text] [Related]
3. Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity.
Huang J; Liu W; Lin BY; Li JC; Lu J; Li BY
Asian J Androl; 2023; 25(2):198-207. PubMed ID: 35975362
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer.
Qi W; Morales C; Cooke LS; Johnson B; Somer B; Mahadevan D
Oncotarget; 2015 Dec; 6(39):41976-87. PubMed ID: 26506516
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of androgen receptors by NaAsO
Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS
Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958
[TBL] [Abstract][Full Text] [Related]
6. Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.
Chattopadhyay I; Wang J; Qin M; Gao L; Holtz R; Vessella RL; Leach RW; Gelman IH
Oncotarget; 2017 Feb; 8(6):10324-10347. PubMed ID: 28055971
[TBL] [Abstract][Full Text] [Related]
7. Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability.
Matsumoto H; Yamamoto Y; Shiota M; Kuruma H; Beraldi E; Matsuyama H; Zoubeidi A; Gleave M
Cancer Res; 2013 Aug; 73(16):5206-17. PubMed ID: 23786771
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
9. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.
Lin HP; Lin CY; Hsiao PH; Wang HD; Jiang SS; Hsu JM; Jim WT; Chen M; Kung HJ; Chuu CP
PLoS One; 2013; 8(12):e82625. PubMed ID: 24349321
[TBL] [Abstract][Full Text] [Related]
10. Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide.
Pilling AB; Hwang C
Prostate; 2019 Aug; 79(11):1347-1359. PubMed ID: 31228231
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of the expressions of 4-HNE and GPC5 with the progression of prostate cancer].
Song Q; Yan HZ; Wang R; Zhang ZY; Zuo QJ; Song X
Zhonghua Nan Ke Xue; 2023 Jan; 29(1):19-24. PubMed ID: 37846827
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
Tanaka Y; Gavrielides MV; Mitsuuchi Y; Fujii T; Kazanietz MG
J Biol Chem; 2003 Sep; 278(36):33753-62. PubMed ID: 12824193
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor levels are upregulated by Akt in prostate cancer.
Ha S; Ruoff R; Kahoud N; Franke TF; Logan SK
Endocr Relat Cancer; 2011 Apr; 18(2):245-55. PubMed ID: 21317204
[TBL] [Abstract][Full Text] [Related]
14. Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer.
Sekine Y; Nakayama H; Miyazawa Y; Arai S; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K
Oncol Lett; 2021 Dec; 22(6):831. PubMed ID: 34691258
[TBL] [Abstract][Full Text] [Related]
15. [Regulatory effect of Skp2 on the expression and transactivation of the androgen receptor in the progression of castration-resistant prostate cancer].
Song YT; Wu KJ; Wang XY; Na YG; Yin CM
Zhonghua Nan Ke Xue; 2016 Feb; 22(2):122-7. PubMed ID: 26939395
[TBL] [Abstract][Full Text] [Related]
16. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
17. The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.
Shorning BY; Dass MS; Smalley MJ; Pearson HB
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630372
[TBL] [Abstract][Full Text] [Related]
18. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells.
Muniyan S; Chen SJ; Lin FF; Wang Z; Mehta PP; Batra SK; Lin MF
Cell Signal; 2015 Nov; 27(11):2261-71. PubMed ID: 26257301
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation.
Yu Y; Zhang Y; Guan W; Huang T; Kang J; Sheng X; Qi J
Mol Cancer Res; 2014 Jun; 12(6):830-42. PubMed ID: 24574517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]